Overexpression of USF increases TGF-β1 protein levels, but G1 phase arrest was not induced in FRTL-5 cells

Journal of Korean Medical Science

Volumn 23, Issue 5, 2008, Pages 870-876

  Kim, Keun Sook ^b   Hye, Seung Jung ^a   Yun, Jae Chung ^a,c   Tae, Sik Jung ^a   Hye, Won Jang ^a   Lee, Myung Shik ^a   Kim, Kwang Won ^a   Jae, Hoon Chung ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Chung Ang University   (South Korea)

Author keywords

FRTL 5 cells; Transforming growth factor beta1; Upstream stimulatory factor

Indexed keywords

THYMIDINE; TRANSFORMING GROWTH FACTOR BETA1; UPSTREAM STIMULATORY FACTOR; USF1 PROTEIN, RAT; USF2 PROTEIN, RAT;

ANIMAL; APOPTOSIS; ARTICLE; BINDING SITE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL LINE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; METABOLISM; PROMOTER REGION; PROTEIN SYNTHESIS; RAT;

ANIMALS; APOPTOSIS; BINDING SITES; CELL CYCLE; CELL LINE; G1 PHASE; GENE EXPRESSION REGULATION; PROMOTER REGIONS, GENETIC; PROTEIN BIOSYNTHESIS; RATS; THYMIDINE; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1; UPSTREAM STIMULATORY FACTORS;

EID: 56049113294     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2008.23.5.870     Document Type: Article

References (30)

1. Sawadogo M, Roeder RG. Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region. Cell 1985; 43: 165-75.
2. Carthew RW, Chodosh LA, Sharp PA. An RNA polymerase II transcription factor binds to an upstream element in the adenovirus major late promoter. Cell 1985; 43: 439-48.
3. Sawadogo M, Van Dyke MW, Gregor PD, Roeder RG. Multiple forms of the human gene-specific transcription factor USF. I. Complete purification and identification of USF from HeLa cell nuclei. J Biol Chem 1988; 263: 11985-93.
4. Sawadogo M. Multiple forms of the human gene-specific transcription factor USF. II. DNA binding properties and transcriptional activity of the purified HeLa USF. J Biol Chem 1988; 263: 11994-2001.
5. Gregor PD, Sawadogo M, Roeder RG. The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimmer. Genes Dev 1990; 4: 1730-40.
6. Sirito M, Walker S, Lin Q, Kozlowski MT, Klein WH, Sawadogo M. Members of the USF family of helix-loop-helix proteins bind DNA as homo- as well as heterodimers. Gene Expr 1992; 2: 231-40.
7. Miyamoto NG, Moncollin V, Wintzerith M, Hen R, Egly JM, Chambon P. Stimulation of in vitro transcription by the upstream element of the adenovirus-2 major late promoter involves a specific factor. Nucleic Acids Res 1984; 12: 8779-99.
8. Yu YT, Manley JL. Generation and functional analyses for base-substitution mutants of the adenovirus 2 major late promoter. Nucleic Acids Res 1984; 12: 9309-21.
9. Luo X, Sawadogo M. Antiproliferative properties of the USF family of helix-loop-helix transcription factors. Proc Natl Acad Sci USA 1996; 93: 1308-13.
10. Qyang Y, Luo X, Lu T, Ismail PM, Krylov D, Vinson C, Sawadogo M. Cell-type-dependent activity of the ubiquitous transcription factor USF in cellular proliferation and transcriptional activation. Mol Cell Biol 1999; 19: 1508-17.
11. Jung HS, Kim KS, Chung YJ, Chung HK, Min YK, Lee MS, Lee MK, Kim KW Chung JH. USF inhibits cell proliferation through delay in G2/M phase in FRTL-5 cells. Endocr J 2007; 54: 275-85.
12. Glick AB. TGF beta1 back to the future: revisiting its role as a transforming growth factor. Cancer Biol Ther 2004; 3: 276-83.
13. Kaklamani VG, Pasche B. Role of TGF-beta in cancer and the potential for therapy and prevention. Expert Rev Anticancer Ther 2004; 4: 649-61.
14. Sun L. Tumor-suppressive and promoting function of transforming growth factor beta. Front Biosci 2004; 9: 1925-35.
15. Pang XP, Park M, Hershman JM. Transforming growth factor-beta blocks protein kinase-A-mediated iodide transport and protein kinase-C-mediated DNA synthesis in FRTL-5 rat thyroid cells. Endocrinology 1992; 131: 45-50.
16. Coppa A, Mincione G, Mammarella S, Ranieri A, Colletta G. Epithelial rat thyroid cell clones, escaping from transforming growth factor beta negative growth control, are still inhibited by this factor in the ability to trap iodide. Cell Growth Differ 1995; 6: 281-90.
17. Asmis LM, Kaempf J, Von Gruenigen C, Kimura ET, Wagner HE, Studer H. Acquired and naturally occurring resistance of thyroid follicular cells to the growth inhibitory action of transforming growth factor-beta 1 (TGF-beta 1). J Endocrinol 1996; 149: 485-96.
18. Carneiro C, Alvarez CV, Zalvide J, Vidal A, Dominguez F. TGF-beta1 actions on FRTL-5 cells provide a model for the physiological regulation of thyroid growth. Oncogene 1998; 16: 1455-65.
19. Weigert C, Brodbeck K, Sawadogo M, Haring HU, Schleicher ED. Upstream stimulatory factor (USF) proteins induce human TGF-beta1 gene activation via the glucose-response element-1013/-1002 in mesangial cells: up-regulation of USF activity by the hexosamine biosynthetic pathway. J Biol Chem 2004; 279: 15908-15.
20. Pang XP, Hershman JM. Transforming growth factor-beta1 resistance in a thyroid cancer model of tumor necrosis factor-alpha resistance. Thyroid 1998; 8: 1065-70.
21. Scholtz B, Kingsley-Kallesen M, Rizzino A. Transcription of the transforming growth factor-beta2 gene is dependent on an E-box located between an essential cAMP response element/activating transcription factor motif and the TATA box of the gene. J Biol Chem 1996; 271: 32375-80.
22. Kingsley-Kallesen M, Luster TA, Rizzino A. Transcriptional regulation of the transforming growth factor-beta2 gene in glioblastoma cells. In Vitro Cell Dev Biol Anim 2001; 37: 684-90.
23. Ravitz MJ, Wenner CE. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta. Adv Cancer Res 1997; 71: 165-207.
24. Massague J, Blain SW, Lo RS. TGF beta signaling in growth control, cancer, and heritable disorders. Cell 2000; 103: 295-309.
25. Ewen ME, Sloss HK, Whitehouse LL, Livingston DM. TGF beta inhibition of CDK4 synthesis is linked to cell cycle arrest. Cell 1993; 74: 1009-20.
26. Iavarone A, Massague J. Repression of the CDK activator cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15. Nature 1997; 387: 417-22.
27. Warner BJ, Blain SW, Seoane J, Massague J. Myc downregulation by transforming growth factor beta required for activation of the p15 (link4b) G(1) arrest pathway. Mol Cell Biol 1999; 19: 5913-22.
28. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323-30.
29. Zetterberg A, Larsson O, Wiman KG. What is the restriction point? Curr Opin Cell Biol 1995; 7: 835-42.
30. Hashimoto O, Ueno T, Kimura R, Ohtsubo M, Nakamura T, Koga H, Torimura T, Uchida S, Yamashita K, Sata M. Inhibition of proteasome-dependent degradation of Wee1 in G2-arrested Hep3B cells by TGF beta 1. Mol Carcinog 2003; 36: 171-82.